These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 33225916)

  • 1. Hepatocellular carcinoma: Intratumoral EpCAM-positive cancer stem cell heterogeneity identifies high-risk tumor subtype.
    Krause J; von Felden J; Casar C; Fründt TW; Galaski J; Schmidt C; Jung C; Ittrich H; Weidemann SA; Krech T; Heumann A; Li J; Fischer L; Sauter G; Lohse AW; Wege H; Schulze K
    BMC Cancer; 2020 Nov; 20(1):1130. PubMed ID: 33225916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer stem cell markers correlate with early recurrence and survival in hepatocellular carcinoma.
    Guo Z; Li LQ; Jiang JH; Ou C; Zeng LX; Xiang BD
    World J Gastroenterol; 2014 Feb; 20(8):2098-106. PubMed ID: 24616575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of microRNAs specific for epithelial cell adhesion molecule-positive tumor cells in hepatocellular carcinoma.
    Ji J; Zheng X; Forgues M; Yamashita T; Wauthier EL; Reid LM; Wen X; Song Y; Wei JS; Khan J; Thorgeirsson SS; Wang XW
    Hepatology; 2015 Sep; 62(3):829-40. PubMed ID: 25953724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-Wide RNAi Screen Identifies PMPCB as a Therapeutic Vulnerability in EpCAM
    Takai A; Dang H; Oishi N; Khatib S; Martin SP; Dominguez DA; Luo J; Bagni R; Wu X; Powell K; Ye QH; Jia HL; Qin LX; Chen J; Mitchell GA; Luo X; Thorgeirsson SS; Wang XW
    Cancer Res; 2019 May; 79(9):2379-2391. PubMed ID: 30862714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Function for KLF4 in Modulating the De-differentiation of EpCAM
    Karagonlar ZF; Akbari S; Karabicici M; Sahin E; Avci ST; Ersoy N; Ates KE; Balli T; Karacicek B; Kaplan KN; Celiker C; Atabey N; Erdal E
    Cells; 2020 May; 9(5):. PubMed ID: 32408542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of preoperative EpCAM Circulating Tumor Cells and peripheral Treg cell levels with early recurrence of hepatocellular carcinoma following radical hepatic resection.
    Zhou Y; Wang B; Wu J; Zhang C; Zhou Y; Yang X; Zhou J; Guo W; Fan J
    BMC Cancer; 2016 Jul; 16():506. PubMed ID: 27439521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic alterations and expression of PTEN and its relationship with cancer stem cell markers to investigate pathogenesis and to evaluate prognosis in hepatocellular carcinoma.
    Chen D; Li Z; Cheng Q; Wang Y; Qian L; Gao J; Zhu JY
    J Clin Pathol; 2019 Sep; 72(9):588-596. PubMed ID: 31126975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EpCAM+ Liver Cancer Stem-Like Cells Exhibiting Autocrine Wnt Signaling Potentially Originate in Cirrhotic Patients.
    Khosla R; Rastogi A; Ramakrishna G; Pamecha V; Mukhopadhyay A; Vasudevan M; Sarin SK; Trehanpati N
    Stem Cells Transl Med; 2017 Mar; 6(3):807-818. PubMed ID: 28176469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection.
    Sun YF; Xu Y; Yang XR; Guo W; Zhang X; Qiu SJ; Shi RY; Hu B; Zhou J; Fan J
    Hepatology; 2013 Apr; 57(4):1458-68. PubMed ID: 23175471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EpCAM-high liver cancer stem cells resist natural killer cell-mediated cytotoxicity by upregulating CEACAM1.
    Park DJ; Sung PS; Kim JH; Lee GW; Jang JW; Jung ES; Bae SH; Choi JY; Yoon SK
    J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32221015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of stem cell marker expression on recurrence of TACE-treated hepatocellular carcinoma post liver transplantation.
    Zeng Z; Ren J; O'Neil M; Zhao J; Bridges B; Cox J; Abdulkarim B; Schmitt TM; Kumer SC; Weinman SA
    BMC Cancer; 2012 Dec; 12():584. PubMed ID: 23216644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EpCAM as a Predictive Marker of Tumor Recurrence and Survival in Patients Who Underwent Surgical Resection for Hepatocellular Carcinoma.
    Noh CK; Wang HJ; Kim CM; Kim J; Yoon SY; Lee GH; Cho HJ; Yang MJ; Kim SS; Hwang JC; Cho SW; Roh J; Kim YB; Kim SJ; Kim BW; Cheong JY
    Anticancer Res; 2018 Jul; 38(7):4101-4109. PubMed ID: 29970536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peritumoral EpCAM Is an Independent Prognostic Marker after Curative Resection of HBV-Related Hepatocellular Carcinoma.
    Dai XM; Huang T; Yang SL; Zheng XM; Chen GG; Zhang T
    Dis Markers; 2017; 2017():8495326. PubMed ID: 28572700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating Cancer Stem Cells Expressing EpCAM/CD90 in Hepatocellular Carcinoma: A Pilot Study for Predicting Tumor Recurrence after Living Donor Liver Transplantation.
    Hwang HS; Yoo JE; Han DH; Choi JS; Lee JG; Joo DJ; Kim MS; Kim SI; Choi GH; Park YN
    Gut Liver; 2022 May; 16(3):443-455. PubMed ID: 34737243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Epithelial Cell Adhesion Molecule Cancer Stem Cell Marker in Evaluation of Hepatocellular Carcinoma.
    El-Kholy MA; Abu-Seadah SS; Hasan A; Elhussiny MEA; Abdelwahed MS; Hanbazazh M; Samman A; Alrashdi SA; Rashed ZF; Ashmawy D; Othman AE; Abdelaleem MF; Abo-Saif AIA; Abdel-Maqsoud RR; Attiah SM; Assiri ES; Nasr M; Ismail KA; Saad DZ; El-Mosely MM
    Medicina (Kaunas); 2024 May; 60(6):. PubMed ID: 38929532
    [No Abstract]   [Full Text] [Related]  

  • 16. High expression of MAGE-A9 contributes to stemness and malignancy of human hepatocellular carcinoma.
    Wei Y; Wang Y; Gong J; Rao L; Wu Z; Nie T; Shi D; Zhang L
    Int J Oncol; 2018 Jan; 52(1):219-230. PubMed ID: 29138811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proliferating EpCAM-Positive Ductal Cells in the Inflamed Liver Give Rise to Hepatocellular Carcinoma.
    Matsumoto T; Takai A; Eso Y; Kinoshita K; Manabe T; Seno H; Chiba T; Marusawa H
    Cancer Res; 2017 Nov; 77(22):6131-6143. PubMed ID: 28951464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EpCAM, a new marker for cancer stem cells in hepatocellular carcinoma.
    Terris B; Cavard C; Perret C
    J Hepatol; 2010 Feb; 52(2):280-1. PubMed ID: 20006402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-26b-5p helps in EpCAM+cancer stem cells maintenance via HSC71/HSPA8 and augments malignant features in HCC.
    Khosla R; Hemati H; Rastogi A; Ramakrishna G; Sarin SK; Trehanpati N
    Liver Int; 2019 Sep; 39(9):1692-1703. PubMed ID: 31276277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of hepatocellular carcinoma by targeting MYCN-positive liver cancer stem cells with acyclic retinoid.
    Qin XY; Suzuki H; Honda M; Okada H; Kaneko S; Inoue I; Ebisui E; Hashimoto K; Carninci P; Kanki K; Tatsukawa H; Ishibashi N; Masaki T; Matsuura T; Kagechika H; Toriguchi K; Hatano E; Shirakami Y; Shiota G; Shimizu M; Moriwaki H; Kojima S
    Proc Natl Acad Sci U S A; 2018 May; 115(19):4969-4974. PubMed ID: 29686061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.